Developing Cystic Fibrosis Lung Transplant Referral Criteria Using Predictors of 2-Year Mortality
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The first objective of our study was to develop a model identifying the best clinical predictors of 2-year mortality among patients with cystic fibrosis (CF), to assist in selection of appropriate candidates for lung transplantation. Using multivariate logistic regression, we found that age, height, FEV1, respiratory microbiology, number of hospitalizations for pulmonary exacerbations, and number of home intravenous antibiotic courses were all significant predictors of 2-year mortality among 14,572 patients in the Cystic Fibrosis Foundation National Patient Registry who were 6 years of age or older in 1996. The second objective was to compare the diagnostic accuracy of our model when used to guide referral for lung transplant with that of the widely used criterion of an FEV1 of less than 30% predicted. Surprisingly, this well-fitting model derived from the largest collection of data available on patients with CF provided no better diagnostic accuracy than the simpler FEV1 criterion. Both had high negative predictive values (98 and 97%, respectively) but only modest positive predictive values (33 and 28%, respectively). Transplant referral decisions based either on a multivariate logistic model or on the criterion of an FEV1 of less than 30% predicted are likely to result in high rates of premature referral. Better clinical predictors of short-term mortality among patients with CF are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FEV1 has been the best individual predictor of mortality in CF, with studies from the 1990s demonstrating a median survival of 2–4 years after reaching an FEV1 < 30% predicted.(242–244)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [242]
In the citing paper
“FEV1 has been the best individual predictor of mortality in CF, with studies from the 1990s demonstrating a median survival of 2–4 years after reaching an FEV1 < 30% predicted.(242–244)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [242]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Basic principles of ROC analysis
Metz, C. E. (1978) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(78)80014-2 · Cited by 6,026
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
Prediction of mortality in patients with cystic fibrosis
Kerem, E., Reisman, J., Corey, M., Canny, G. J., & Levison, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261804 · Cited by 993
The changing epidemiology of cystic fibrosis
FitzSimmons, S. C. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83478-x · Cited by 928
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
United Network for Organ Sharing
Goodman, C. S. (1988) · Cited by 742
International Guidelines for the Selection of Lung Transplant Candidates
(1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.15812 · Cited by 365
ARIS, R. M., ROUTH, J. C., LiPUMA, J. J., HEATH, D. G., & GILLIGAN, P. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2107022 · Cited by 256
Pulmonary Function in Idiopathic Pulmonary Fibrosis and Referral for Lung Transplantation
MOGULKOC, N., BRUTSCHE, M. H., BISHOP, P. W., GREAVES, S. M., HORROCKS, A. W., & EGAN, J. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2007077 · Cited by 238
Infection with Burkholderia cepacia in Cystic Fibrosis: Outcome Following Lung Transplantation
CHAPARRO, C., MAURER, J., GUTIERREZ, C., KRAJDEN, M., CHAN, C., WINTON, T., KESHAVJEE, S., SCAVUZZO, M., TULLIS, E., HUTCHEON, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.9811076 · Cited by 232
Survival Effect of Lung Transplantation Among Patients With Cystic Fibrosis
Liou, T. G. (2001) · JAMA · doi:10.1001/jama.286.21.2683 · Cited by 175
Risk of death in cystic fibrosis patients with severely compromised lung function
Milla, C. E., & Warwick, W. J. (1998) · Chest · doi:10.1378/chest.113.5.1230 · Cited by 167
Lung Transplantation in Cystic Fibrosis
Yankaskas, J. R., & Mallory, G. B. (1998) · CHEST Journal · doi:10.1378/chest.113.1.217 · Cited by 155
Outcome of Patients with Cystic Fibrosis Awaiting Lung Transplantation
VIZZA, C. D., YUSEN, R. D., LYNCH, J. P., FEDELE, F., ALEXANDER PATTERSON, G., & TRULOCK, E. P. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910102 · Cited by 97
A model for predicting life expectancy of children with cystic fibrosis
Aurora, P., Wade, A., Whitmore, P., & Whitehead, B. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16f06.x · Cited by 95
A prognostic model for the prediction of survival in cystic fibrosis
Hayllar, K. M., Williams, S. G., Wise, A. E., Pouria, S., Lombard, M., Hodson, M. E., & Westaby, D. (1997) · Thorax · doi:10.1136/thx.52.4.313 · Cited by 86
Lung Transplantation for Cystic Fibrosis
Kotloff, R. M., & Zuckerman, J. B. (1996) · CHEST Journal · doi:10.1378/chest.109.3.787 · Cited by 56
Flume, P. A. (1998) · CHEST Journal · doi:10.1378/chest.113.5.1159 · Cited by 13
Cystic Fibrosis: The Prognosis for Five-year Survival
Knoke, J. D., Stern, R. C., Doershuk, C. F., Boat, T. F., & Matthews, L. W. (1978) · Pediatric Research · doi:10.1203/00006450-197805000-00012 · Cited by 11
FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis
Robinson, W., & Waltz, D. A. (2000) · Pediatric Pulmonology · doi:10.1002/1099-0496(200009)30:3<198::aid-ppul3>3.0.co;2-e
Research works printed but not linked: 1
- 1993, J Pediatr, 122, 1
Cited by
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
“37 Another study evaluated patients with CF referred for transplantation at four lung transplant centers.”
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
ECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Metadata
- Authors
- Mayer-Hamblett, N., Rosenfeld, M., Emerson, J., Goss, C. H., & Aitken, M. L.
- Affiliations
- Seattle Children's Hospital (US)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12
- Volume
- 166
- Issue
- 12
- Pages
- 1550-1555
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2141642277
- Cited by
- 269
- References
- 23
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 12 · 2020: 17 · 2019: 14 · 2018: 18 · 2017: 23 · 2016: 13 · 2015: 17 · 2014: 18 · 2013: 8 · 2012: 15
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (K23RR015529, K23 RR15529)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- cystic fibrosis, lung transplantation, 2-year mortality, mortality risk factors, FEV1, pulmonary exacerbations, intravenous antibiotics, respiratory microbiology, diagnostic accuracy
- MeSH terms
- Adult, Bacterial Infections, Child, Cystic Fibrosis, Female, Humans, Male, Predictive Value of Tests, Registries, Respiratory Function Tests, Logistic Models, Lung Transplantation, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.